Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Erik Hack

Showing results (141-150 of 165) with videos related to

Pageof 17
Sort By:
Scientific Reports|May 25, 2016
Soluble CD59 is a Novel Biomarker for the Prediction of Obstructive Chronic Lung Allograft Dysfunction After Lung TransplantationKevin Budding, Eduard A van de Graaf, Tineke Kardol-Hoefnagel, et al.
Blood|January 5, 2002
Expression of the granzyme B inhibitor, protease inhibitor 9, by tumor cells in patients with non-Hodgkin and Hodgkin lymphoma: a novel protective mechanism for tumor cells to circumvent the immune system?Bellinda A Bladergroen, Chris J L M Meijer, Rosita L ten Berge, et al.
Critical Care (London, England)|December 20, 2018
Effect of cytomegalovirus reactivation on the time course of systemic host response biomarkers in previously immunocompetent critically ill patients with sepsis: a matched cohort studyKirsten van de Groep, Stefan Nierkens, Olaf L Cremer, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 10, 2021
Cytokine receptor clustering in sensory neurons with an engineered cytokine fusion protein triggers unique pain resolution pathwaysJudith Prado, Remco H S Westerink, Jelena Popov-Celeketic, et al.
Clinical and Experimental Rheumatology|June 8, 2019
Increased intra-articular granzyme M may trigger local IFN-λ1/IL-29 response in rheumatoid arthritisLiling Shan, Lucas L van den Hoogen, Jan Meeldijk, et al.
The Journal of Allergy and Clinical Immunology|July 25, 2016
Human amniotic fluid antibodies protect the neonate against respiratory syncytial virus infectionShamir R Jacobino, Maaike Nederend, Marije Hennus, et al.
The Journal of Infectious Diseases|January 1, 2003
Effects of IC14, an anti-CD14 antibody, on coagulation and fibrinolysis during low-grade endotoxemia in humansAnnelies Verbon, Joost C M Meijers, C Arnold Spek, et al.
Cardiovascular Research|June 18, 2014
Leucocyte expression of complement C5a receptors exacerbates infarct size after myocardial reperfusion injuryVince C De Hoog, Leo Timmers, Amerik Van Duijvenvoorde, et al.
Molecular Immunology|May 9, 2007
Human mast cells produce and release the cytotoxic lymphocyte associated protease granzyme B upon activationMerel C M Strik, Pieter J A de Koning, Monique J Kleijmeer, et al.
Nature Communications|August 16, 2025
Randomized phase I trial outcomes show safe and sustainable inhibition of classical and lectin complement pathways by empasiprubartInge Van de Walle, Laura Bracke, Heidi Gytz Olesen, et al.
Pageof 17

Showing results (141-150 of 165) with videos related to

Sort By:
Pageof 17
Scientific Reports|May 25, 2016
Soluble CD59 is a Novel Biomarker for the Prediction of Obstructive Chronic Lung Allograft Dysfunction After Lung TransplantationKevin Budding, Eduard A van de Graaf, Tineke Kardol-Hoefnagel, et al.
Blood|January 5, 2002
Expression of the granzyme B inhibitor, protease inhibitor 9, by tumor cells in patients with non-Hodgkin and Hodgkin lymphoma: a novel protective mechanism for tumor cells to circumvent the immune system?Bellinda A Bladergroen, Chris J L M Meijer, Rosita L ten Berge, et al.
Critical Care (London, England)|December 20, 2018
Effect of cytomegalovirus reactivation on the time course of systemic host response biomarkers in previously immunocompetent critically ill patients with sepsis: a matched cohort studyKirsten van de Groep, Stefan Nierkens, Olaf L Cremer, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 10, 2021
Cytokine receptor clustering in sensory neurons with an engineered cytokine fusion protein triggers unique pain resolution pathwaysJudith Prado, Remco H S Westerink, Jelena Popov-Celeketic, et al.
Clinical and Experimental Rheumatology|June 8, 2019
Increased intra-articular granzyme M may trigger local IFN-λ1/IL-29 response in rheumatoid arthritisLiling Shan, Lucas L van den Hoogen, Jan Meeldijk, et al.
The Journal of Allergy and Clinical Immunology|July 25, 2016
Human amniotic fluid antibodies protect the neonate against respiratory syncytial virus infectionShamir R Jacobino, Maaike Nederend, Marije Hennus, et al.
The Journal of Infectious Diseases|January 1, 2003
Effects of IC14, an anti-CD14 antibody, on coagulation and fibrinolysis during low-grade endotoxemia in humansAnnelies Verbon, Joost C M Meijers, C Arnold Spek, et al.
Cardiovascular Research|June 18, 2014
Leucocyte expression of complement C5a receptors exacerbates infarct size after myocardial reperfusion injuryVince C De Hoog, Leo Timmers, Amerik Van Duijvenvoorde, et al.
Molecular Immunology|May 9, 2007
Human mast cells produce and release the cytotoxic lymphocyte associated protease granzyme B upon activationMerel C M Strik, Pieter J A de Koning, Monique J Kleijmeer, et al.
Nature Communications|August 16, 2025
Randomized phase I trial outcomes show safe and sustainable inhibition of classical and lectin complement pathways by empasiprubartInge Van de Walle, Laura Bracke, Heidi Gytz Olesen, et al.
Pageof 17